Laxmi Dental

Who are the top shareholders of the Laxmi Dental?

The top shareholders of Laxmi Dental include promoters, with Rajesh Vrajlal Khakhar holding 16.91%, and 27 Foreign Institutional Investors (FIIs) owning 34.24%. The highest public shareholder is Orbimed Asia II Mauritius Limited at 22.41%, while individual investors hold 6.49%.

The top shareholders of Laxmi Dental include a mix of promoters, institutional investors, and public shareholders. The majority shareholders are the promoters, with Rajesh Vrajlal Khakhar holding the highest stake at 16.91%. Among institutional investors, 27 Foreign Institutional Investors (FIIs) collectively hold 34.24%, while 16 mutual fund schemes account for 11.89% of the shares. The highest public shareholder is Orbimed Asia II Mauritius Limited, which holds 22.41%. Additionally, individual investors have a combined holding of 6.49%.

Has Laxmi Dental declared dividend?

No Dividend History Available

Who are the peers of the Laxmi Dental?

Laxmi Dental's peers include Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Krsnaa Diagnost., Tarsons Products, Suraksha Diagno., and 3B Blackbio. In terms of management risk, growth, and capital structure, Laxmi Dental is rated as good, while its 1-year return is not available for comparison.

Peers: The peers of Laxmi Dental are Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Krsnaa Diagnost., Tarsons Products, Suraksha Diagno., and 3B Blackbio.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dr Lal Pathlabs and Laxmi Dental, while Good management risk is found at Syngene Intl., Poly Medicure, Indegene, Vijaya Diagnost., and the rest. Average management risk is noted at Krsnaa Diagnost. and Suraksha Diagno., while Below Average management risk is seen at Tarsons Products and Sastasundar Ven. In terms of Growth, Laxmi Dental shows Good growth, while Average growth is found at Poly Medicure and Indegene, and Below Average growth is observed at Syngene Intl., Dr Lal Pathlabs, Vijaya Diagnost., Krsnaa Diagnost., and the rest. Excellent capital structure is noted at Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., and Krsnaa Diagnost., while Good capital structure is seen at Laxmi Dental and Suraksha Diagno., and Below Average capital structure is found at Tarsons Products and Sastasundar Ven.<BR><BR>Return Snapshot: The peer with the highest 1-year return is 3B Blackbio at 84.85%, while the peer with the lowest is Tarsons Products at -6.26%. Laxmi Dental's 1-year return is not available for comparison. Additionally, Krsnaa Diagnost. and Tarsons Products have negative six-month returns.

What does Laxmi Dental do?

Laxmi Dental Ltd is a small-cap healthcare services company that specializes in dental care, with recent net sales of 607 Cr and a net profit of 43 Cr as of March 2025. The company was incorporated in 2004 and became publicly listed in 2024.

Overview: <BR>Laxmi Dental Ltd operates in the healthcare services industry and is categorized as a small-cap company.<BR><BR>History: <BR>Laxmi Dental Limited was incorporated in 2004 as Laxmi Dental Export Private Limited. The company underwent a name change to Laxmi Dental Private Limited in June 2024 and subsequently converted to a public company as Laxmi Dental Limited in August 2024. The most recent quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 607 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 43 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 2,600 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 99.00 <BR>Industry P/E: 53 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.43 <BR>Return on Equity: 12.82% <BR>Price to Book: 12.31 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Laxmi Dental?

As of 24th July, Laxmi Dental Ltd has a market capitalization of 2,572.00 Cr, with recent Net Sales of 234.51 Cr and a Net Profit of 22.48 Cr. Shareholder's Funds are reported at 42.47 Cr, and Total Assets amount to 123.26 Cr as of March 2024.

As of 24th July, Laxmi Dental Ltd has a market capitalization of 2,572.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Laxmi Dental reported Net Sales of 234.51 Cr and a Net Profit of 22.48 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds reported at 42.47 Cr and Total Assets amounting to 123.26 Cr.

How has been the historical performance of Laxmi Dental?

Laxmi Dental has shown significant growth over the past three years, with net sales increasing from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25, and profit after tax turning from a loss of 4.45 Cr to a profit of 25.37 Cr. The company's operating profit margin improved from 5.54% to 17.7%, reflecting a strengthening financial position.

Answer:<BR>The historical performance of Laxmi Dental shows significant growth over the past three years, particularly in revenue and profitability.<BR><BR>Breakdown:<BR>Laxmi Dental's net sales have increased from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25, reflecting a strong upward trend. The total operating income has followed suit, rising from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25. The company's operating profit (PBDIT) has also seen substantial growth, moving from 11.17 Cr in Mar'23 to 45.21 Cr in Mar'25, with an operating profit margin that improved from 5.54% to 17.7% over the same period. Profit before tax turned positive, reaching 31.83 Cr in Mar'25, compared to a loss of 4.26 Cr in Mar'23, while profit after tax rose from a loss of 4.45 Cr to a profit of 25.37 Cr. The consolidated net profit increased from a loss of 3.97 Cr in Mar'23 to 31.77 Cr in Mar'25. On the balance sheet, total assets grew significantly from 96.38 Cr in Mar'23 to 278.22 Cr in Mar'25, driven by increases in cash and bank balances and total reserves. Total liabilities also rose, but at a slower pace, from 96.38 Cr to 278.22 Cr, indicating a strengthening financial position. Cash flow from operating activities improved dramatically, reaching 43 Cr in Mar'25, compared to only 8 Cr in Mar'24, contributing to a net cash inflow of 125 Cr in Mar'25, a significant turnaround from previous years.

Is Laxmi Dental overvalued or undervalued?

As of December 4, 2025, Laxmi Dental is considered overvalued with a high PE ratio of 57.86 and other elevated valuation metrics, despite respectable returns on capital and equity, and has underperformed the Sensex recently.

As of 4 December 2025, Laxmi Dental has moved from a fair to an expensive valuation grade. The company is currently overvalued, as indicated by its high PE ratio of 57.86, a Price to Book Value of 6.75, and an EV to EBITDA of 36.56. In comparison to its peers, Laxmi Dental's valuation metrics are significantly higher, with Lenskart Solutions having a PE of 237.94 and Poly Medicure at 53.38, both categorized as very expensive.<BR><BR>The company's return on capital employed (ROCE) stands at 12.57% and return on equity (ROE) at 11.66%, which, while respectable, do not justify the current high valuation. Recent stock performance shows Laxmi Dental's price has fluctuated, with a current price of 281.40, but it has underperformed the Sensex over the past month, which could reinforce concerns about its valuation. Overall, Laxmi Dental appears to be overvalued in the current market context.

When is the next results date for Laxmi Dental Ltd?

The next results date for Laxmi Dental Ltd is 10 February 2026.

The next results date for Laxmi Dental Ltd is scheduled for 10 February 2026.

Which are the latest news on Laxmi Dental?

Why is Laxmi Dental Ltd falling/rising?

As of 09-Feb, Laxmi Dental Ltd's stock price is rising to 223.10, reflecting a 9.74% increase after two days of decline. However, despite this short-term recovery, the stock has significant long-term declines and decreased investor participation, indicating ongoing challenges.

As of 09-Feb, Laxmi Dental Ltd's stock price is rising, currently at 223.10, reflecting a change of 19.8 or 9.74%. This increase follows a trend reversal, as the stock has gained after two consecutive days of decline. Today, it opened with a gain of 2.48% and reached an intraday high of Rs 224.65, which is a 10.5% increase. The stock has outperformed its sector by 4.46%, indicating positive momentum in comparison to the broader market.<BR><BR>Despite this rise, it's important to note that the stock has experienced a significant decline over longer periods, with a year-to-date decrease of 17.92% and a one-year drop of 52.52%. Additionally, while the stock is currently trading above its 5-day and 20-day moving averages, it remains below its 50-day, 100-day, and 200-day moving averages, suggesting that while there is short-term strength, the longer-term trend may still be weak.<BR><BR>Investor participation has decreased, with delivery volume falling by 66.85% against the 5-day average, which could indicate a lack of confidence among investors despite the current price rise. Overall, the stock's recent performance reflects a short-term recovery amidst a backdrop of longer-term challenges.